• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.29% Nasdaq Up 0.19%

    Arrowhead Pharmaceuticals, Inc. (ARWR)

    -NasdaqGS
    1.87 Up 0.02(1.08%) Mar 24, 4:00PM EDT
    |After Hours : 1.87 0.00 (0.00%) Mar 24, 4:00PM EDT
    Prev Close:1.85
    Open:1.87
    Bid:1.75 x 100
    Ask:2.66 x 500
    1y Target Est:1.80
    Beta:1.18095
    Earnings Date:May 8 - May 12 (Est.)
    Day's Range:1.83 - 1.93
    52wk Range:1.20 - 8.22
    Volume:264,294
    Avg Vol (3m):1,170,830
    Market Cap:139.45M
    P/E (ttm):N/A
    EPS (ttm):-1.17
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARWR

    Comparison

    Symbol% ChgMkt Cap
    ARWRUp 1.08%139.45M
    PENCUp 6.87%3.87M
    1 0.00%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):30.79
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Sep-17) :-0.49
    Quarterly EPS Est (Mar-17) :-0.12
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):-0.55

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arrowhead Pharmaceuticals, Inc. develops novel drugs to treat intractable diseases in the United States. Its pre-clinical stage drug candidates include ARO-HBV to treat chronic hepatitis B virus infection; ARO-AAT to treat liver disease associated... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback